Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.
Neuro Oncol. 2023 Nov 2;25(11):2044-2057. doi: 10.1093/neuonc/noad097.
Neuro Oncol. 2023.
PMID: 37246765
Free PMC article.
Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.
Osum SH, Oribamise EI, Corbière SMAS, Taisto M, Jubenville T, Coutts A, Kirstein MN, Fisher J, Moertel C, Du M, Bedwell D, Largaespada DA, Watson AL.
Osum SH, et al.
Mol Ther Nucleic Acids. 2023 Jun 26;33:227-239. doi: 10.1016/j.omtn.2023.06.018. eCollection 2023 Sep 12.
Mol Ther Nucleic Acids. 2023.
PMID: 37520682
Free PMC article.
Item in Clipboard
Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1.
Osum SH, Watson AL, Largaespada DA.
Osum SH, et al.
Int J Mol Sci. 2021 Feb 16;22(4):1954. doi: 10.3390/ijms22041954.
Int J Mol Sci. 2021.
PMID: 33669386
Free PMC article.
Review.
Item in Clipboard
Intestinal CD8αα IELs derived from two distinct thymic precursors have staggered ontogeny.
Ruscher R, Lee ST, Salgado OC, Breed ER, Osum SH, Hogquist KA.
Ruscher R, et al. Among authors: osum sh.
J Exp Med. 2020 Aug 3;217(8):e20192336. doi: 10.1084/jem.20192336.
J Exp Med. 2020.
PMID: 32687575
Free PMC article.
Item in Clipboard
Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.
Osum SH, Coutts AW, Duerre DJ, Tschida BR, Kirstein MN, Fisher J, Bell WR, Delpuech O, Smith PD, Widemann BC, Moertel CL, Largaespada DA, Watson AL.
Osum SH, et al.
Neurooncol Adv. 2021 Feb 10;3(1):vdab020. doi: 10.1093/noajnl/vdab020. eCollection 2021 Jan-Dec.
Neurooncol Adv. 2021.
PMID: 33978635
Free PMC article.
Item in Clipboard
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma.
Smeester BA, Slipek NJ, Pomeroy EJ, Laoharawee K, Osum SH, Larsson AT, Williams KB, Stratton N, Yamamoto K, Peterson JJ, Rathe SK, Mills LJ, Hudson WA, Crosby MR, Wang M, Rahrmann EP, Moriarity BS, Largaespada DA.
Smeester BA, et al. Among authors: osum sh.
Bone. 2020 Jul;136:115353. doi: 10.1016/j.bone.2020.115353. Epub 2020 Apr 3.
Bone. 2020.
PMID: 32251854
Item in Clipboard
Cite
Cite